THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 93 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $536,124 | +14.0% | 63,222 | +20.6% | 0.00% | – |
Q1 2024 | $470,199 | -17.0% | 52,419 | +4.0% | 0.00% | – |
Q4 2023 | $566,429 | +18.5% | 50,394 | -9.0% | 0.00% | – |
Q3 2023 | $477,939 | -19.3% | 55,381 | -3.2% | 0.00% | – |
Q2 2023 | $591,979 | -3.9% | 57,196 | +0.7% | 0.00% | – |
Q1 2023 | $616,227 | -0.8% | 56,795 | +2.5% | 0.00% | – |
Q4 2022 | $621,486 | +9.8% | 55,391 | -0.8% | 0.00% | – |
Q3 2022 | $566,000 | +6.0% | 55,859 | -5.2% | 0.00% | – |
Q2 2022 | $534,000 | -2.7% | 58,904 | +2.6% | 0.00% | – |
Q1 2022 | $549,000 | -13.4% | 57,388 | -0.0% | 0.00% | – |
Q4 2021 | $634,000 | +100.6% | 57,397 | +34.3% | 0.00% | – |
Q3 2021 | $316,000 | -31.0% | 42,749 | +35.6% | 0.00% | – |
Q2 2021 | $458,000 | -27.8% | 31,525 | +1.5% | 0.00% | – |
Q1 2021 | $634,000 | +14.2% | 31,064 | -0.6% | 0.00% | – |
Q4 2020 | $555,000 | +19.9% | 31,265 | 0.0% | 0.00% | – |
Q3 2020 | $463,000 | -34.1% | 31,265 | -6.7% | 0.00% | – |
Q2 2020 | $703,000 | -10.4% | 33,495 | -1.5% | 0.00% | – |
Q1 2020 | $785,000 | +21.5% | 33,988 | +36.3% | 0.00% | – |
Q4 2019 | $646,000 | +42.9% | 24,940 | +7.6% | 0.00% | – |
Q3 2019 | $452,000 | +33.3% | 23,178 | +11.5% | 0.00% | – |
Q2 2019 | $339,000 | -26.3% | 20,790 | +2.5% | 0.00% | – |
Q1 2019 | $460,000 | -6.5% | 20,290 | +5.4% | 0.00% | – |
Q4 2018 | $492,000 | +9.6% | 19,244 | +40.0% | 0.00% | – |
Q3 2018 | $449,000 | +43.9% | 13,742 | 0.0% | 0.00% | – |
Q2 2018 | $312,000 | -13.6% | 13,742 | -7.7% | 0.00% | – |
Q1 2018 | $361,000 | -38.9% | 14,881 | -29.6% | 0.00% | – |
Q4 2017 | $591,000 | -8.5% | 21,140 | +12.2% | 0.00% | – |
Q3 2017 | $646,000 | -0.5% | 18,840 | +15.7% | 0.00% | -100.0% |
Q2 2017 | $649,000 | +12.7% | 16,289 | +3.7% | 0.00% | – |
Q1 2017 | $576,000 | +28.6% | 15,713 | +11.6% | 0.00% | – |
Q4 2016 | $448,000 | – | 14,082 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Avenue Partners, LP | 8,511,350 | $72,176,248 | 9.12% |
Newtyn Management, LLC | 2,124,703 | $18,017,481 | 3.38% |
Irenic Capital Management LP | 2,760,948 | $23,412,839 | 2.86% |
Weiss Asset Management LP | 7,457,060 | $63,235,869 | 2.39% |
Oasis Management Co Ltd. | 1,157,965 | $9,819,543 | 2.21% |
Park West Asset Management LLC | 1,700,000 | $14,416,000 | 1.06% |
Baupost Group | 4,200,021 | $35,616 | 0.98% |
Camber Capital Management LP | 1,000,000 | $8,480 | 0.24% |
Virtus ETF Advisers LLC | 38,386 | $325,513 | 0.16% |
GSA CAPITAL PARTNERS LLP | 204,089 | $1,731 | 0.12% |